[Skip to Content]
[Skip to Content Landing]
August 1973

Surgical Therapy of Fibrosarcoma of ExtremitiesA Reappraisal

Author Affiliations

New York
From the Gastric and Mixed Tumor Service, Department of Surgery (Drs. Castro and Fortner) and the Department of Pathology (Dr. Hajdu), Memorial Sloan-Kettering Cancer Center, New York.

Arch Surg. 1973;107(2):284-286. doi:10.1001/archsurg.1973.01350200146030

During an 18-year period from 1949 to 1967 at Memorial Sloan-Kettering Cancer Center, 75 patients with fibrosarcoma of the extremities had definitive surgical therapy with an overall five- and ten-year survival of 70% and 60%, respectively, and a local recurrence rate of 28%. Soft part resection was attempted in all cases. Amputation was done where adequate margin could not be obtained as determined by site and size of tumor; neurovascular, bone, or joint involvement; and multicentric origin. Results indicate that a second local recurrence justifies amputation. Regional lymph node dissection is not indicated. The determining factor in death of patients due to fibrosarcoma is distant metastasis, 78% of which is pulmonary.